Antibody-Drug Conjugates

Overview

Antibody-drug conjugates (ADCs) are targeted biologics that place unique demands on manufacturing infrastructure. Antibody-drug conjugates place unique demands on infrastructure originally designed for simpler biologics, spanning containment and safety, analytical characterization, and batch-to-batch consistency.